ALB vs ALKS · $8.00B cap vs P/E 14, rev $1.56B
Albemarle Corp (ALB) versus Alkermes Plc (ALKS) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
ALB does not have a complete income-statement cache yet.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
ALB currently screens at market cap $8.00B. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Not investment advice. Open the ALB and ALKS stock pages for the full models.
Not investment advice.